Hatem Halabi, MD, FACS
Dr. Hatem Halabi is a surgical oncologist with the City of Hope in Chicago. He is skilled in minimally invasive, robotic surgery, operating on patients with a few tiny incisions using technology designed to provide greater precision and improved access to hard-to-reach areas. He primarily focuses on surgeries for gynecologic (ovarian, cervical, uterine, and vulvar), colorectal, and gastric cancers, as well as for malignant peritoneal mesothelioma, a rare asbestos-related cancer that he treats using a complex surgical procedure that combines cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.[1]
Education and Career
Dr. Halabi earned a bachelor’s degree in Chemistry at the American University in Beirut, Lebanon. He completed a medical degree there and then moved on to the Medical College of Virginia in Richmond, Virginia, where he completed an internship and residency in General Surgery, as well as a fellowship in Surgery, Medical Informatics, and Telemedicine. He also completed a Surgical Oncology fellowship at The Institute for Cancer Care at Mercy Health Services in Baltimore Maryland.[1]
Following the completion of his medical education and training, Dr. Halabi served as the Director of Surgical Oncology at the Virginia Hospital Center in Arlington, Virginia; as an assistant professor of surgery at Georgetown University. He also spent several years in positions of responsibility with Cancer Treatment Centers of America.[1]
Research
Dr. Halabi is a dedicated researcher and educator. He studied translational research in clinical oncology at the National Cancer Institute in Bethesda, Maryland, and has lectured widely on surgical oncology. His work has been published in several eminent medical journals and he has presented his research at numerous professional conferences.
His recent publications include:[2]
Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series. Olsi Gjyshi, Pankaj G. Vashi, Laura Seewald, Mitra Kohan, Elham Abboud, Eric Fowler, Revathi Suppiah, Hatem M. El Halabi>; World Journal of Surgical Oncology. 2018 Jul 14
Neoplasms of the appendix: current treatment guidelines. Suven Shankar, Panayotis Ledakis, Hatem El Halabi, Vadim Gushchin, Armando Sardi>; Hematology/Oncology Clinics of North America. 2012 Dec 1
Four times repeated isolated limb infusion with melphalan-controlled locoregional disease in the patient with melanoma of the leg. Hatem El Halabi, Fadi Hijaz, Vadim Gushchin>; The American Surgeon. 2012 Dec 1
Terri Heimann Oppenheimer
WriterTerri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Dave Foster
Page EditorDave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.
References
- City of Hope. (N.D.). Hatem Halabi, MD, FACS.
Retrieved from: https://www.cancercenter.com/physician-directory/hatem-halabi - Doximity. (N.D.). Hatem Halabi, MDFACS.
Retrieved from: https://www.doximity.com/pub/hatem-halabi-md